WASHINGTON, D.C. (WREX) — A U.S. Senator from Illinois has introduced new legislation that would lift federal barriers and increase research into marijuana.
Senator Dick Durbin (D-IL) introduced the Expanding Cannabis Research and Information Act, which would remove restrictions on federal research.
The legislation would also expand potential benefits and harms from the use of marijuana.
“With some form of legalization on the books in over 30 states and now Illinois, I want to lift federal restrictions so we can conduct additional medical research on marijuana,” Durbin said. “We need a better understanding of promising uses of cannabis for treatment, as well as how marijuana use impacts public safety and specific populations – including children, pregnant women, and drivers.”
Under federal law, cannabis and its derivatives are classified by the Drug Enforcement Administration (DEA) as Schedule I controlled substances, defined as having no medical benefit. This classification imposes restrictions on the access to and use of cannabis in scientific research.
Durbin says because of these restrictions, researches have more hurdles to jump through. The new legislation would:
- Direct the NIH, CDC, and SAMHSA to develop a national cannabis research agenda. The agenda would prioritize key questions and gaps in evidence-including a study of diseases with the greatest potential benefit; how marijuana affects vulnerable populations; long-term effects; different modes of delivery; and public safety concerns.
- Direct HHS to collect more data on cannabis use and impacts on health outcomes. Using public health surveys and analysis of public medical records, this would expand public health data collection on health outcomes and the variety of products used.
- Reclassify cannabis from a Schedule I to a Schedule III controlled substance. This will remove barriers that researchers face in accessing supply of cannabis and credentialing staff/facilities to demonstrate safety and capacity to study cannabis.
- Establish an NIH research “Centers of Excellence” designation. The designation would streamline research by enabling qualified universities to undergo a single DEA facility/staff inspection that lasts for the entire 5-10 year duration, rather than needing specific approvals for each study and researcher. Additionally, the designation would expand the number of approved suppliers for marijuana cultivation for research.